| O’Brien, Ron (Thermo Fisher 201003 Director Public Relations) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| O’Bryan-Tear, Gillies (Algeta 201112 CMO) |
Chief Medical Officer (CMO) |
Bayer (Group) |
Norway |
| O’Callaghan, Brian (Petra Pharma 201804 CEO) |
Chief Executive Officer (CEO) |
Petra Pharma Corporation |
United States (USA) |
| O’Connell, Alan (Seroba Life Sciences 201702 Partner joined 2003 before Elan Corp + American Biogenetic Sciences) |
Partner (venture partner) |
Seroba (Group) |
Ireland, Republic of |
| O’Connell, Christopher J. (Chris) (Waters 201509–202009 CEO before over 21 years at Medtronic) |
Chief Executive Officer (CEO) |
Waters (Group) |
United States (USA) |
| O’Connor, Chris (Techcomp 201309 CEO of Techcomp Europe before Barloworld Scientific CEO) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
United Kingdom (GB) |
| O’Day, Daniel (Gilead 201903– CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| O’Dowd, Hugh (Neon Therapeutics 20201 CEO) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
United States (USA) |
| O’Leary, Ciarán (BY Capital 201509– Managing Director) |
Managing Director |
BY Capital (BlueYard Capital) (Group) |
Germany |
| O’Neill, Julie (Hookipa 201811– non-exec Board Member as well as at DBV Technologies before Alexion + Gilead) |
Board member, non-executive |
Hookipa (Group) |
United States (USA) |
| O’Riordan, Paul (Synexa Life Sciences 202205 Chairman) |
Board member, non-executive |
Synexa Life Sciences (Group) |
Finland |
| O’Shea, Donal (Danaher 201110 Head of Digital Pathology at Leica Microsystems) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Germany |
| Paal, Jürgen (Proteo Biotech 201412– COO before Fresenius Medical Care) |
Chief Operating Officer (COO) |
Proteo Biotech (Group) |
Germany |
| Pacitti, David (Siemens 202104 President + Head of the Americas at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Germany |
| Pack, Peter (mtm laboratories 1999–200806 CEO + founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
Germany |
| Padrosa, David Roura (inSEIT AG 202405 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
inSEIT AG |
Switzerland |
| Padula, Steven (Boehringer Ingelheim 201503 Therapeutic Area Head Medicine Immunology) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
| Paetzke, Christian (Roche 202008 Managing Director of Roche Diagnostics Germany) |
Managing Director |
Roche (Group) |
Germany |
| Paez, Vincent (Danaher 201302 Senior Director Food + Environmental at AB Sciex) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Paffrath, Eric (EOS Group 201910 Managing Director of EOS GmbH) |
Managing Director |
EOS Group (Electro Optical Systems) (Group) |
Germany |
| Paganelli, Jennifer (W2O Group 201703) |
Public Relations Manager / Investor Relations Manager |
Real Chemistry (WeissComm Group) (Group) |
United States (USA) |
| Page, Mark (HH2E 202206 Board Member + Co-Founder) |
Board member, executive |
HH2E (Group) |
Germany |
| Pagel, Philipp (Numares 201707 CMO) |
Chief Medical Officer (CMO) |
Numares (Group) |
Germany |
| Pahl, Andreas (Wilex 201606– Head of RnD before CSO at Heidelberg Pharma) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Heidelberg Pharma (Group) |
Germany |
| Pairet, Michel (Boehringer 201009 head Boehringer Ingelheim Venture Fund) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Palacin, Patrick (iAtros GmbH 202003 Managing Director + Co-Founder) |
Managing Director |
iAtros GmbH |
Germany |
| Palay, Robert (Cellular Dynamics 201004 CEO) |
Chief Executive Officer (CEO) |
Fujifilm (Group) |
United States (USA) |
| Palazzo, Guido (Univ Lausanne 202309 Prof of Business Ethics) |
Professor |
University of Lausanne (UNIL) |
Switzerland |
| Palu, Michel (Norlab 201108 Managing Director + founder in 1992) |
Managing Director |
Norlab (Group) |
Finland |
| Pammolli, Fabio (Schaffhausen Institute of Technology 202208 President of Jacobs University Bremen) |
President/Director/Head of Research Organisation/Unit |
Schaffhausen Institute of Technology (SIT) |
Germany |
| Pan, Elisa (Eureka Therapeutics 201505 Head Business Operations) |
Chief Business Officer (CBO) |
Eureka Therapeutics Inc. |
United States (USA) |
| Pandey, Sue (NuGen 200605) |
Chief Commercial Officer (CCO) |
Tecan (Group) |
United States (USA) |
| Pangratz, Christian M. (Atriva Therapeutics 202301– CEO before Sterna Biologicals + Secarna + Vectura + Sykepharma) |
Managing Director |
Sterna Biologicals (Genova) (Group) |
Germany |
| Pankau, Wolf-Peter (Thüringen (govt) 201211 LEG Thüringen Project Head Life Sciences) |
Cluster Manager |
Thuringia (govt region) |
Germany |
| Panne, Ulrich (Germany (govt) 201409 President of BAM + Humboldt Univ Professor) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Pantel, Klaus (Univ Hamburg 201504 Professor + Head Dept Tumor Biology at UKE) |
Professor |
University of Hamburg |
Germany |
| Panten, Hartmut (Roche 201106 Communications Roche Penzberg) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
Germany |
| Panter, Ben (Blackford Analysis 202301 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United Kingdom (GB) |
| Panting, Robert (Rentschler 202110– General Manager of Rentschler ATMP Ltd before Fujifilm Diosynth Biotechnologies) |
General Manager (management) |
Rentschler (Group) |
United Kingdom (GB) |
| Panzner, Steffen (Lipocalyx 201106– Managing Director + Founder) |
Managing Director |
Lipocalyx GmbH |
Germany |
| Pao, William (Roche 201804– Head of Pharma Research and Early Development pRED joined 2014 before Vanderbilt Univ) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Papadaki-Markley, Jane (Immunexpress 201909– VP Market Development + Commercial before Wafergen + ApoCell + Asuragen) |
Business Development Manager / Strategy Manager |
Immunexpress (Group) |
United States (USA) |
| Papadakis, Michalis (Brainomix 201804 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Brainomix Ltd. |
United Kingdom (GB) |
| Papadimitriou, Apollon (iOmx Therapeutics 201910– CEO joined 2017 as CDO before Roche) |
Chief Executive Officer (CEO) |
iOmx Therapeutics AG |
Germany |
| Papatheodorou, Elias (HepaRegenix 202407– CEO before Genkyotex + Covagen + Medigene + Novosom + A.T.I. + Coca-Cola) |
Chief Executive Officer (CEO) |
HepaRegenix GmbH |
Germany |
| Papaz, Greg (Paion 201410– CEO of Paion Inc before Optimer Pharmaceuticals + Roche + Sanofi) |
Chief Executive Officer (CEO) |
Humanwell Healthcare (Group) |
United States (USA) |
| Papiernik, Antoine (Sofinnova Partners 201703 Managing Partner + Chairman joined 1997) |
Managing Partner (investment firm) |
Sofinnova (Group) |
France |
| Paprotka, Tobias (GATC Biotech 201211 Head of Development) |
Research & Development Manager |
Eurofins (Group) |
Germany |
| Papst, Daniel (Papst 202301 Managing Director + Co-Owner of Papst Venture Capital GmbH) |
Managing Director |
Papst (Group) |
Germany |
| Pâques, Eric-Paul (Grühnenthal 201402 CEO before Head of Research at Behringwerke) |
Chief Executive Officer (CEO) |
Grünenthal (Group) |
Germany |
| Pâques, Frédéric (Global Bioenergies 201702 COO) |
Chief Operating Officer (COO) |
Global Bioenergies (Group) |
France |
| Paracchi, Pierluigi (Genenta Science Srl 201709 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Genenta Science (Group) |
Italy |
| Paranjape, Ketan (Intel 201604 General Manager Life Sciences) |
General Manager (management) |
Intel (Group) |
United States (USA) |
| Parekh, Nayan Gregory (Biocartis 201111– CEO before Executive Director before New Rhein Healtchare + Novartis) |
Chief Executive Officer (CEO) |
Biocartis (Group) |
Switzerland |
| Parel, Serge (Exquiron Biotech AG 201306 VP Chemistry + Research Informatics) |
Research & Development Manager |
Evotec (Group) |
Switzerland |
| Parera, Daniel (IcanoMab 202009 Co-CEO + CMO before TVM + Novartis + McKinsey) |
Chief Executive Officer (CEO) |
IcanoMab GmbH |
Germany |
| Parge, Hans (Proteros 201008– technical ambassador in US former Director Structural Biology Pfizer La Jolla) |
Business Development Manager / Strategy Manager |
Proteros (Group) |
United States (USA) |
| Parhizgar, Azin (415 Capital 202404 Senior Venture Partner + Board Chair of Protembis 202403) |
Venture Partner |
415 Capital Management GmbH |
Germany |
| Parikh, Tobias |
n. a. |
LSA Life Science Agency GmbH |
Germany |
| Parikhal, Lauren (BMC Commnications 201801) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Parisot, Jean-Yves (Symrise 202403– CEO joined 2014 before Diana Group + Air Liquide + Danisco) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Germany |
| Park, Jungsoo (PL Bioscience 202408 VP of Marketing + Sales formerly BioLizard 201909 Director BusDev) |
Business Development Manager / Strategy Manager |
PL BioScience GmbH |
Germany |
| Park, Melvin (Bruker 201606 Director of Research at Bruker Daltonics) |
Research & Development Manager |
Bruker (Group) |
United States (USA) |
| Park, Robin (Bruker 202009– Head of Bioinformatics Team in San Diego before CEO of Integrated Proteomics Applications) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Parker, Andrew (Step Pharma 201909– CEO before Zealand Pharma + Eclosion2 + AstraZeneca + JnJ + Opsana Therapeutics) |
Chief Executive Officer (CEO) |
Step Pharma SAS |
France |
| Parker, Paul G. (Thermo Fisher 202004– SVP Strategy + Corporate Development before Goldman Sachs + Barclays) |
Corporate Strategy Manager |
Thermo Fisher (Group) |
United States (USA) |
| Parkin, Glyn (Boehringer Ingelheim 201505 Corporate SVP + Metabolism Head) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Parkinson, Jr., Robert L. (Baxter 200612 Chairman + CEO) |
Chief Executive Officer (CEO) |
Baxter (Group) |
United States (USA) |
| Parmar, Harsukh (Merck (DE) 201404 Head Translational Innovation Platform at Merck Serono) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Paronneau, Anthony (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) |
Attorney / Lawyer |
McDermott Will & Emery (MWE) (Group) |
France |
| Parotelli, Roberto (Bayer Healthcare 200804 Head Diabetes Care Europe) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Parr, Maria (FU Berlin 201909 Professor) |
Professor |
Freie Universität Berlin (FU Berlin, Free University Berlin) |
Germany |
| Parrett, William G. (Deloite Touche –2007 retired) |
n. a. |
Deloitte Touche Tohmatsu (Group) |
United Kingdom (GB) |
| Parrisius, Jürgen (ActeaVentures 201403– Managing Partner before JP BioConsulting + Pfizer + Roche + Cardion) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Parry, Rob (AvanSci Bio 201412 CEO) |
Chief Executive Officer (CEO) |
AvanSci Bio LLC |
United States (USA) |
| Parthoens, Alain (Newton Biocapital 201810 Managing Director before Vesalius Biocapital) |
Managing Partner (investment firm) |
Newton Biocapital (NBC) (Group) |
Belgium |
| Paschinger, Ira (PR&D (AT) 201805) |
Public Relations Manager / Investor Relations Manager |
PR&D – Public Relations für Forschung & Bildung GmbH |
Austria |
| Paschlau, Joachim (ERC GmbH 201105 Managing Director) |
Managing Director |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Germany |
| Pasini, Alexandre (Celonic 202110– COO before SaniSure Group + Lonza Group) |
Chief Operating Officer (COO) |
Celonic (Group) |
Switzerland |
| Pasquier, Olivier (Prestodiag 201405 VP Sales + Marketing before Abaxxi + Cytoo + Qiagen) |
Sales Manager / Marketing Manager |
Prestodiag SAS |
France |
| Passmore, David (Yumab 202005 Business Development) |
Business Development Manager / Strategy Manager |
Yumab (Group) |
United States (USA) |
| Pasternack, Ralf (Zedira 201106 Managing Director + co-founder before N-Zyme Biotec 200506 Managing Director) |
Managing Director |
Zedira GmbH |
Germany |
| Patel, Dhavalkumar (Dhaval) (UCB 201802 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
UCB (Group) |
Belgium |
| Patel, Dipal (Valneva 202211– Chief Commercial Officer before GSK) |
Chief Commercial Officer (CCO) |
Valneva (Group) |
France |
| Patel, Sanjay S. (Immunic 201907– CFO before Pernix Therapeutics + Cantor Fitzgerald + Clinton Foundation + Cowen) |
Chief Financial Officer (CFO) |
Immunic (Group) |
United States (USA) |
| Patel, Umesh A. (Merck (DE) 201112 Direct Lead Discovery at EMD Millipore) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Paterson, Andrew (Merck (DE) 202312 Chief Marketing Officer for Healthcare Business) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
Germany |
| Patneaude, Joe (Kendall Investor Relations 202306) |
Public Relations Manager / Investor Relations Manager |
Kendall Investor Relations LLC |
United States (USA) |
| Pattberg, Holger (CMS 201806 Counsel at CMS) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Pauer, Michael (Occident Group 201604 Investment Director) |
Investment Manager |
Occident (Group) |
Switzerland |
| Paul, Les (Molecular Health 201607– CMO based in Boston before Caris Life Sciences + Intermune + Novartis) |
Chief Medical Officer (CMO) |
Molecular Health (Group) |
Germany |
| Paul, Wolfgang (Univ Bonn Professor *1913–+1993) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Pauli, Peter (BayBG 201110 Managing Director) |
Managing Director |
Bavaria (govt region) |
Germany |
| Paulick, Katharina (BioNukleo GmbH 201808 Managing Partner) |
Managing Director |
BioNukleo GmbH |
Germany |
| Paulista, Michael (Biopharm GmbH 201311 Managing Director) |
Managing Director |
Biopharm (Group) |
Germany |
| Paulitschke, Manrico (Provitro GmbH 201210 Managing Director) |
Managing Director |
Provitro AG |
Germany |
| Paulsen, Frederik (Ferring 201911 Chairman) |
Board member |
Ferring (Paulsen Foundation) (Group) |
Switzerland |
| Paulsen, Richard (Ipsen 201801– EVP + CEO North America before 10 years at Amgen) |
Regional manager |
Ipsen (Group) |
France |
| Paust, Thomas (Sartorius 201204 VP Supply Chain Management at Sartorius Stedim Biotech) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Pauwels, Rudi (Biocartis 201111 Executive Chairman before 201002–201111 CEO) |
Chief Executive Officer (CEO) |
Biocartis (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 59 60 61 ... 91 92 93 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
